Drug price disruption: Will the new Amazon deal have an impact?

A recent analysis by reporter Erin Mershon in STAT  offers five reasons why it is so very difficult to make drugs more affordable, despite President Trump’s repeated vow to lower prices. The five factors are:

Can the ASCO “Value Framework” work for myeloma patients?

Cancer drug costs are high. In an effort to rationalize the use of expensive drugs, the American Society of Clinical Oncology (ASCO) has proposed what they call a “Value Framework.” This framework uses a complex points system (See Fig 1. of article).